down arrow

Taiko Pharmaceutical Co., Ltd.

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: JP3442200006
  • TKS: 4574
JPY
257.00
-1 (-0.39%)

Sep 18

TKS

 View all stocks in this country
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationQuarterly Results
Results Snapshot
YoYQoQ
Figures in Million
Consolidate Quarterly Results
Jun'26
Mar'26
Dec'25
Sep'25
Jun'25
Mar'25
Dec'24
Net Sales
1,720.00
916.00
2,168.00
1,817.00
1,262.00
1,150.00
1,713.00
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
1,720.00
916.00
2,168.00
1,817.00
1,262.00
1,150.00
1,713.00
Raw Material Cost
882.00
415.00
1,048.00
777.00
620.00
471.00
762.00
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
1.00
0.00
1.00
1.00
2.00
1.00
2.00
Selling and Distribution Expenses
723.00
598.00
986.00
763.00
639.00
634.00
1,048.00
Other Expenses
-0.10
0.00
-0.10
-0.10
-0.20
-0.10
-0.20
Total Expenditure (Excl Depreciation)
1,605.00
1,013.00
2,034.00
1,540.00
1,259.00
1,105.00
1,810.00
Operating Profit (PBDIT) excl Other Income
115
-97
134
277
3
45
-97
Other Income
19.00
5.00
23.00
14.00
7.00
316.00
91.00
Operating Profit (PBDIT)
209.00
-19.00
229.00
359.00
75.00
421.00
60.00
Interest
1.00
0.00
1.00
1.00
2.00
1.00
2.00
Exceptional Items
0.00
0.00
-20.00
151.00
4.00
10.00
-99.00
Gross Profit (PBDT)
838.00
501.00
1,120.00
1,040.00
642.00
679.00
951.00
Depreciation
75.00
73.00
72.00
68.00
65.00
60.00
66.00
Profit Before Tax
134.00
-94.00
137.00
439.00
14.00
368.00
-108.00
Tax
-4.00
0.00
-117.00
49.00
26.00
76.00
-291.00
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
139.00
-95.00
254.00
390.00
-13.00
292.00
184.00
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
139.00
-95.00
254.00
390.00
-13.00
292.00
184.00
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
139.00
-95.00
254.00
390.00
-13.00
292.00
184.00
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
0.0
0.0
0.0
0.0
0.0
0.0
0.0
Reserves
8,425.00
8,264.00
8,518.00
8,236.00
7,948.00
7,979.00
7,964.00
Earnings per share (EPS)
2.77
-1.89
5.05
7.76
-0.26
5.82
3.67
Diluted Earnings per share
2.77
-1.89
5.05
7.76
-0.26
5.82
3.67
Operating Profit Margin (Excl OI)
6.69%
-10.59%
6.18%
15.24%
0.24%
3.91%
-5.66%
Gross Profit Margin
12.15%
-2.29%
9.64%
27.9%
6.26%
37.22%
-2.45%
PAT Margin
8.08%
-10.37%
11.72%
21.46%
-1.03%
25.39%
10.74%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Quarterly Analysis Highlights - QoQ
stock-summary

Net Sales

QoQ Growth in quarter ended Jun 2026 is 87.77% vs -57.75% in Mar 2026

stock-summary

Consolidate Net Profit

QoQ Growth in quarter ended Jun 2026 is 246.32% vs -137.40% in Mar 2026

stock-summary

Operating Profit (PBDIT) excl Other Income

QoQ Growth in quarter ended Jun 2026 is 891.67% vs -111.65% in Mar 2026

stock-summary

Interest

QoQ Growth in quarter ended Jun 2026 is 0.00% vs -100.00% in Mar 2026

stock-summary

Operating Profit Margin (Excl OI)

QoQ Growth in quarter ended Jun 2026 has improved from Mar 2026

Compare Quarterly Results Of Taiko Pharmaceutical Co., Ltd. With
Markets Mojo
Figures in Million
Consolidate Quarterly Results
Markets Mojo
Markets Mojo
Change(JPY)
Change(%)
Net Sales
1,720.00
16,046.00
-14,326.00
-89.28%
Other Operating Income
0.00
0.00
0.00
Total Operating income
1,720.00
16,046.00
-14,326.00
-89.28%
Raw Material Cost
882.00
11,848.00
-10,966.00
-92.56%
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
0.00
0.00
Power Cost
0
0
0.00
Manufacturing Expenses
1.00
104.00
-103.00
-99.04%
Selling and Distribution Expenses
723.00
3,225.00
-2,502.00
-77.58%
Other Expenses
-0.10
-10.40
10.30
99.04%
Total Expenditure (Excl Depreciation)
1,605.00
15,073.00
-13,468.00
-89.35%
Operating Profit (PBDIT) excl Other Income
115.00
973.00
-858.00
-88.18%
Other Income
19.00
-38.00
57.00
150.00%
Operating Profit (PBDIT)
209.00
1,588.00
-1,379.00
-86.84%
Interest
1.00
104.00
-103.00
-99.04%
Exceptional Items
0.00
82.00
-82.00
-100.00%
Gross Profit (PBDT)
838.00
4,198.00
-3,360.00
-80.04%
Depreciation
75.00
653.00
-578.00
-88.51%
Profit Before Tax
134.00
911.00
-777.00
-85.29%
Tax
-4.00
268.00
-272.00
-101.49%
Provisions and contingencies
0
0
0.00
Profit After Tax
139.00
642.00
-503.00
-78.35%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
139.00
642.00
-503.00
-78.35%
Share in Profit of Associates
0
0
0.00
Minority Interest
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
Consolidated Net Profit
139.00
642.00
-503.00
-78.35%
Equity Capital
0
0
0.00
Face Value
0.00
0.00
0.00
Reserves
8,425.00
35,751.00
-27,326.00
-76.43%
Earnings per share (EPS)
2.77
75.21
-72.44
-96.32%
Diluted Earnings per share
2.77
75.21
-72.44
-96.32%
Operating Profit Margin (Excl OI)
6.69%
6.06%
0.00
0.63%
Gross Profit Margin
12.15%
9.75%
0.00
2.40%
PAT Margin
8.08%
4.00%
0.00
4.08%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Quarterly - Net Sales
Net Sales 172.00 Million
in Jun 2026

Figures in Million
stock-summary

QoQ Growth in quarter ended Jun 2026 is 87.77% vs -57.75% in Mar 2026

stock-summary

YoY Growth in quarter ended Jun 2026 is 36.29% vs -14.90% in Jun 2025

Quarterly - Consolidate Net Profit
Consolidate Net Profit 13.90 Million
in Jun 2026

Figures in Million
stock-summary

QoQ Growth in quarter ended Jun 2026 is 246.32% vs -137.40% in Mar 2026

stock-summary

YoY Growth in quarter ended Jun 2026 is 1,169.23% vs -104.45% in Jun 2025

Quarterly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 19.00 Million
in Jun 2026

Figures in Million
stock-summary

QoQ Growth in quarter ended Jun 2026 is 891.67% vs -111.65% in Mar 2026

stock-summary

YoY Growth in quarter ended Jun 2026 is 179.41% vs -79.58% in Jun 2025

Quarterly - Interest
Interest 0.10 Million
in Jun 2026

Figures in Million
stock-summary

QoQ Growth in quarter ended Jun 2026 is 0.00% vs -100.00% in Mar 2026

stock-summary

YoY Growth in quarter ended Jun 2026 is -50.00% vs 0.00% in Jun 2025

Quarterly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 6.69%
in Jun 2026

Figures in %
stock-summary

QoQ Growth in quarter ended Jun 2026 has improved from Mar 2026

stock-summary

YoY Growth in quarter ended Jun 2026 has improved from Jun 2025

Footer loading